
Predictive Oncology POAI
Quarterly report 2025-Q3
added 11-14-2025
Predictive Oncology ROA Ratio 2011-2026 | POAI
Annual ROA Ratio Predictive Oncology
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -254.69 | -96.99 | -100.01 | -44.91 | -198.19 | -86.66 | -271.95 | -213.74 | -232.45 | -85.05 | -758.46 | -1594.92 | -2005.41 | -997.78 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -44.91 | -2005.41 | -495.8 |
Quarterly ROA Ratio Predictive Oncology
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2618.29 | -184.44 | -154.22 | -111.12 | -128.53 | -104.67 | -93.33 | -49.78 | -62.02 | -56.85 | -66.61 | -53.81 | -64.43 | -62.82 | -38.87 | -24.95 | -73.25 | -110.92 | -133.79 | -110.37 | -128.28 | -97.9 | -63.96 | -26.08 | -93.67 | -143.35 | -213.89 | -179.03 | -206.41 | -166.19 | -172.38 | -311.3 | -543.75 | -748.82 | -911.08 | -697.34 | -782.39 | -635.0 | -423.6 | -110.11 | -233.89 | -272.61 | -444.24 | -495.92 | -1165.75 | -1711.79 | -1717.21 | -1222.05 | -1994.75 | -2097.62 | -2477.43 | -1543.62 | -1650.61 | -984.91 | -514.01 | -1219.52 | -106.99 | -106.99 | -1005.53 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -24.95 | -2618.29 | -541.07 |
ROA Ratio of other stocks in the Medical instruments industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
-1.75 | $ 29.85 | 1.05 % | $ 1.43 B | ||
|
AngioDynamics
ANGO
|
-12.13 | $ 10.6 | -1.03 % | $ 433 M | ||
|
Luminex Corporation
LMNX
|
1.84 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-161.51 | - | -9.52 % | $ 20.6 M | ||
|
Atrion Corporation
ATRI
|
7442.15 | - | - | $ 810 M | ||
|
Harvard Bioscience
HBIO
|
-2.49 | $ 0.47 | -4.15 % | $ 19.9 M | ||
|
Alcon
ALC
|
1.34 | $ 77.32 | -1.5 % | $ 40.4 B | ||
|
Antares Pharma, Inc.
ATRS
|
26.44 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
0.66 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-12.76 | - | - | $ 282 M | ||
|
ICU Medical
ICUI
|
0.02 | $ 125.85 | -2.28 % | $ 3.1 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
4.77 | - | -0.05 % | $ 10.3 B | ||
|
InfuSystem Holdings
INFU
|
0.02 | $ 9.31 | -0.85 % | $ 192 M | ||
|
iRhythm Technologies
IRTC
|
-4.37 | $ 113.0 | -1.46 % | $ 3.62 B | ||
|
Intuitive Surgical
ISRG
|
13.96 | $ 472.16 | -1.48 % | $ 169 B | ||
|
The Cooper Companies
COO
|
3.02 | $ 69.92 | -2.24 % | $ 13.9 B | ||
|
Varian Medical Systems, Inc.
VAR
|
7.12 | - | -0.02 % | $ 16.3 B | ||
|
Glaukos Corporation
GKOS
|
-14.32 | $ 97.02 | -0.79 % | $ 4.7 B | ||
|
Becton, Dickinson and Company
BDX
|
3.03 | $ 159.36 | -0.17 % | $ 45.8 B | ||
|
Haemonetics Corporation
HAE
|
6.84 | $ 59.92 | 0.72 % | $ 3.02 B | ||
|
electroCore
ECOR
|
-116.97 | $ 6.14 | -3.0 % | $ 33.9 K | ||
|
Masimo Corporation
MASI
|
-11.61 | $ 175.49 | -0.01 % | $ 9.35 B | ||
|
Isoray
ISR
|
-23.24 | - | 0.03 % | $ 108 M | ||
|
Ekso Bionics Holdings
EKSO
|
-58.15 | $ 11.56 | -2.12 % | $ 28 M | ||
|
Repro Med Systems
KRMD
|
-9.35 | $ 4.28 | -0.7 % | $ 198 M | ||
|
Baxter International
BAX
|
-4.77 | $ 17.4 | -3.36 % | $ 8.93 B | ||
|
BioLife Solutions
BLFS
|
-5.05 | $ 18.36 | 1.16 % | $ 846 M | ||
|
Nephros
NEPH
|
-13.28 | $ 3.5 | -7.89 % | $ 36.4 M | ||
|
ResMed
RMD
|
15.3 | $ 230.84 | -0.68 % | $ 33.7 B | ||
|
Retractable Technologies
RVP
|
-7.4 | $ 0.71 | 2.62 % | $ 21.3 M | ||
|
NeuroMetrix
NURO
|
-50.94 | - | 5.05 % | $ 9.02 M | ||
|
Merit Medical Systems
MMSI
|
4.78 | $ 69.95 | 2.61 % | $ 4.14 B | ||
|
Envista Holdings Corporation
NVST
|
0.83 | $ 24.61 | -3.26 % | $ 4.13 B | ||
|
STAAR Surgical Company
STAA
|
-17.81 | $ 18.84 | 2.45 % | $ 934 M | ||
|
Stereotaxis
STXS
|
-41.42 | $ 1.89 | 0.27 % | $ 172 M | ||
|
Teleflex Incorporated
TFX
|
-10.28 | $ 107.32 | -0.87 % | $ 4.79 B | ||
|
OraSure Technologies
OSUR
|
-17.05 | $ 2.97 | -3.88 % | $ 218 M | ||
|
LeMaitre Vascular
LMAT
|
9.38 | $ 108.06 | 1.43 % | $ 2.45 B | ||
|
Utah Medical Products
UTMD
|
3.16 | $ 63.28 | 1.02 % | $ 230 M | ||
|
Pro-Dex
PDEX
|
14.67 | $ 48.46 | 3.5 % | $ 159 M | ||
|
Microbot Medical
MBOT
|
-128.98 | $ 2.69 | -1.47 % | $ 27.4 M | ||
|
West Pharmaceutical Services
WST
|
11.56 | $ 235.46 | 1.89 % | $ 17 B | ||
|
Repligen Corporation
RGEN
|
1.26 | $ 114.2 | 0.39 % | $ 6.36 M | ||
|
DENTSPLY SIRONA
XRAY
|
-11.01 | $ 11.54 | -2.2 % | $ 2.3 B | ||
|
Pulse Biosciences
PLSE
|
-76.99 | $ 21.57 | 1.27 % | $ 1.45 B | ||
|
STERIS plc
STE
|
6.06 | $ 214.57 | 1.05 % | $ 21.2 B | ||
|
Milestone Scientific
MLSS
|
-48.11 | $ 0.28 | -3.75 % | $ 22.3 M |